JOHNSON INVESTMENT COUNSEL INC - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 57 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JOHNSON INVESTMENT COUNSEL INC ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$111,284
+35.2%
46,7580.0%0.00%0.0%
Q2 2023$82,294
-42.9%
46,7580.0%0.00%
-50.0%
Q1 2023$144,015
-41.9%
46,7580.0%0.00%
-33.3%
Q4 2022$247,817
+50.2%
46,7580.0%0.00%
+50.0%
Q3 2022$165,000
+36.4%
46,7580.0%0.00%0.0%
Q2 2022$121,000
-42.1%
46,7580.0%0.00%
-33.3%
Q1 2022$209,000
-34.3%
46,7580.0%0.00%
-25.0%
Q4 2021$318,000
-6.7%
46,7580.0%0.00%
-20.0%
Q3 2021$341,000
-27.3%
46,7580.0%0.01%
-16.7%
Q2 2021$469,000
+4.9%
46,7580.0%0.01%
-14.3%
Q1 2021$447,00046,7580.01%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$9,254,0002.96%
SECTORAL ASSET MANAGEMENT INC 1,053,779$9,347,0000.80%
Pentwater Capital Management LP 4,879,490$43,281,0000.56%
Vivo Capital, LLC 926,449$8,218,0000.48%
Boxer Capital, LLC 1,251,055$11,097,0000.38%
Ikarian Capital, LLC 228,000$2,022,0000.15%
Perceptive Advisors 787,745$6,987,0000.10%
Rock Springs Capital Management LP 367,499$3,260,0000.08%
PURA VIDA INVESTMENTS, LLC 148,949$1,321,0000.07%
PIPER SANDLER & CO. 8,298$74,0000.06%
View complete list of POSEIDA THERAPEUTICS INC shareholders